The company describes OEA as a newly discovered lipid mediator involved in the regulation of feeding.
Chemi Nutra (White Bear Lake, MN) will showcase PhosphoLean NOPE+EGCG, a novel, proprietary hunger-control ingredient whose mechanism of action involves oleoyl ethanolamide (OEA). The company describes OEA as a newly discovered lipid mediator involved in the regulation of feeding, and a natural compound responsible for signaling the brain to stop hunger sensations. “Thus,” the company says, “PhosphoLean NOPE+EGCG shuts down hunger, stops binge eating and diet stress, and reduces food intake-leading to long-term diet success and successful weight loss.” It says PhosphoLean NOPE+EGCG has been clinically proven to help dieters.
Chemi Nutra, Booth 630
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.